drugset / Trial / NCT00002394

Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment

NCT00002394

Completed 30 enrolled Novartis
Parallel-groupTreatment

Summary

The purpose of this study is to see if it is safe and effective to give Lamisil to HIV-positive patients with thrush (a fungal infection) that has not responded to fluconazole.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Terbinafine Small molecule 1500 mg
Subject Terbinafine Small molecule 2000 mg